Morgan Stanley Reiterates Overweight Rating on CME Group Inc. (CME)

Market Context

CME Group Inc. operates in the Financial Services sector. The stock currently trades at $240.27 with a market capitalization of $98.2B. The stock has declined 13.1% over the past 52 weeks.

Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CME Group Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for CME Group Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 10, 2026	Morgan Stanley	Overweight	N/A
Jul 09, 2026	Barclays	Equal-Weight	N/A
Jul 06, 2026	UBS	Neutral	N/A
Jul 02, 2026	Raymond James	Outperform	N/A
Jun 18, 2026	Keefe, Bruyette & Woods	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View CME Stock Page